ArticleActa pharmacologica Sinica2026
β-Sitosterol ameliorates metabolic dysfunction-associated steatohepatitis by targeting the RAC1/mTOR/TFEB axis thus activating lipophagy-lysosomal pathway.
Yang Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.